| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968713 | Vaccine | 2012 | 5 Pages |
Abstract
⺠Strong need for new vaccine technologies. ⺠Nucleic acid vaccines have potential to address current gaps. ⺠RNA-based vaccines have potential to overcome limitations of plasmid DNA and viral vector vaccines. ⺠RNA vaccines have progressed into human clinical trials.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jeffrey B. Ulmer, Peter W. Mason, Andrew Geall, Christian W. Mandl,